A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen
Completed · Phase 2 · Has a placebo group
Conditions studied: Hypertension
In brief
A Phase 2 trial to evaluate the blood pressure-lowering effect of lorundrostat an aldosterone synthase inhibitor (ASI), administered as an add-on to a standardized anti-hypertensive (AHT) medication regimen, in subjects with hypertension.
Key facts
- Study ID
- NCT05769608
- Run by
- Mineralys Therapeutics Inc.
- People needed
- 285
- Starts
- 2023-03-13
- Expected to finish
- 2025-01-15
- Last updated by the study team
- 2026-01-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- At least 18 years of age at the time of signing the informed consent form
- At Screening: AOBP SBP of 140-180 mmHg and AOBP DBP of 65-110 mmHg, or AOBP DBP of 90-110 mmHg
- 24-hour average ABPM SBP of 130-180 mmHg or 24-hour average ABPM DBP >80 mmHg
- Taking between 2 and 5 AHT medications, inclusive, at Screening visit.
- BMI of 18-40 kg/m2 inclusive at Screening
You may not qualify if…
- eGFR <45 mL/min/1.73 m2 at Screening, calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula
- Serum potassium >5.0 mmol/L at Screening or >4.8 mmol/L at Randomization
- Serum sodium <135 mmol/L at Screening
- History of heart failure, myocardial infarction, stroke, or transient ischemic attack within 6 months prior to Screening.
- Diabetes mellitus with a glycosylated hemoglobin (HbA1c) >9% (>74.9 mmol/mol) at Screening
Where it is running
- University of Alabama at Birmingham (UAB) - Vascular Biology and Hypertension Program — Birmingham, Alabama, United States
- Chandler Clinical Trials — Chandler, Arizona, United States
- Brown Road Family Medicine — Mesa, Arizona, United States
- Scottsdale Clinical Trials (Elite Clinical Network) — Scottsdale, Arizona, United States
- Fiel Family & Sports Medicine — Tempe, Arizona, United States
- Noble Clinical Research — Tucson, Arizona, United States
- Del Sol Research Management, LLC — Tucson, Arizona, United States
- The Medical Research Group Inc. — Fresno, California, United States
- Marvel Clinical Research — Huntington Beach, California, United States
- University of California San Diego (UCSD) - Altman Clinical and Translational Research Institute (ACTRI) — La Jolla, California, United States
- Clinical Trials Research — Lincoln, California, United States
- Cedars-Sinai Medical Center — Los Angeles, California, United States
- Catalina Research Institute — Montclair, California, United States
- Northridge Clinical Trials — Northridge, California, United States
- University of California Irvine Medical Center — Orange, California, United States
- Triwest Research Associates — San Diego, California, United States
- San Jose Clinical Trials — San Jose, California, United States
- Blue Coast Research Center — Vista, California, United States
- Accelerated Enrollment Solutions (AES)- Vista — Vista, California, United States
- Delta Waves, Inc. — Colorado Springs, Colorado, United States
- CMR of Greater New Haven — Hamden, Connecticut, United States
- Indago Research & Health Center, Inc. — Hialeah, Florida, United States
- Clinical Neuroscience Solutions, Inc (Jacksonville) — Jacksonville, Florida, United States
- Reserka, LLC — Miami, Florida, United States
- Cardiology, P.C. - Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.